Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for July 22nd

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 22nd:

Delta Air Lines, Inc. (DAL - Free Report) : This scheduled air transportation provider for passengers and cargo has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 5.7% over the last 60 days.

Delta Air Lines has a price-to-earnings ratio (P/E) of 8.66, compared with 10.30 for the industry. The company possesses a Value Score of A.

Elevate Credit, Inc. (ELVT - Free Report) : This provider of online credit solutions to non-prime consumers has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 3.4% over the last 60 days.

Elevate Credit has a price-to-earnings ratio (P/E) of 7.07, compared with 8.60 for the industry. The company possesses a Value Score of A.

Hawaiian Holdings, Inc. (HA - Free Report) : This provider of scheduled air transportation of passengers and cargo has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 4.5% over the last 60 days.

Hawaiian Holdings has a price-to-earnings ratio (P/E) of 6.96, compared with 10.30 for the industry. The company possesses a Value Score of A.

Mr. Cooper Group Inc. (COOP - Free Report) : This transaction-based services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 3.3% over the last 60 days.

Mr. Cooper has a price-to-earnings ratio (P/E) of 4.90 compared with 8.60 for the industry. The company possesses a Value Score of B.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>